Next Article in Journal
Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease
Next Article in Special Issue
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)
Previous Article in Journal
GPER Agonist G1 Prevents Wnt-Induced JUN Upregulation in HT29 Colorectal Cancer Cells
Previous Article in Special Issue
Recent Advances in Renal Medullary Carcinoma
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2022, 23(20), 12614; https://doi.org/10.3390/ijms232012614
Action Date Notes Link
article xml file uploaded 20 October 2022 13:38 CEST Original file -
article xml uploaded. 20 October 2022 13:38 CEST Update https://www.mdpi.com/1422-0067/23/20/12614/xml
article pdf uploaded. 20 October 2022 13:38 CEST Version of Record https://www.mdpi.com/1422-0067/23/20/12614/pdf
article html file updated 20 October 2022 13:40 CEST Original file -
article html file updated 28 February 2023 19:06 CET Update -
article html file updated 1 March 2023 23:15 CET Update https://www.mdpi.com/1422-0067/23/20/12614/html
Back to TopTop